Jim Cramer says the consumer economy is in great shape, but the business economy is a different story. He wants the Fed to pay attention.

Jim Cramer weighs in on Waste Management, Idexx Laboratories, TriplePoint Venture Growth, Cato Corp., Paycom Software, New Residential Investment and more.

Jim Cramer weighs in on Bank of America, YY, Okta, Sarepta Therapeutics, Wendy's, ADT, New Residential Investment, First Interstate Bancshares and more.

On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.

Jim Cramer makes sense of this market action and has your game plan for next week.

Jim Cramer takes a closer look at Bank of America, Kemet, Boston Beer, Diageo, Pilgrim's Pride, Tyson Foods, Moderna and more.

Jim Cramer takes a closer look at Magellan Midstream Partners, Xylem, Boston Scientific, Karyopharm Thereapeutics, Iovance Biotherapeutics, Casella Waste Systems and more.

Jim Cramer says higher rates always trigger rotations. Here's what investors should expect.

Jim Cramer focuses on Tower Semiconductor, Momo, New Residential Investment and Netease.

Amyris is showing progress in one key area, but it may not be enough.

The disgraced investor and convicted felon launched a cryptocurrency last July after his release from prison.

The National Highway Transit Safety Administration received over 50 complaints over brake hose ruptures.